5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
4.85%
Gross profit growth under 50% of UPM.HE's 72.37%. Michael Burry would be concerned about a severe competitive disadvantage.
-106.45%
Negative EBIT growth while UPM.HE is at 1141.38%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-106.45%
Negative operating income growth while UPM.HE is at 1141.38%. Joel Greenblatt would press for urgent turnaround measures.
-48.94%
Negative net income growth while UPM.HE stands at 715.38%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.48%
Negative EPS growth while UPM.HE is at 714.75%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-48.48%
Negative diluted EPS growth while UPM.HE is at 714.75%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
62.27%
Positive OCF growth while UPM.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
78.55%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-10.52%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-6.75%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-11.35%
Negative 3Y CAGR while UPM.HE stands at 15.68%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
282.17%
10Y OCF/share CAGR above 1.5x UPM.HE's 72.42%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
313.21%
5Y OCF/share CAGR above 1.5x UPM.HE's 8.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
52.30%
3Y OCF/share CAGR above 1.5x UPM.HE's 31.50%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-92.17%
Negative 10Y net income/share CAGR while UPM.HE is at 341.27%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-95.17%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-95.17%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
126.55%
10Y equity/share CAGR above 1.5x UPM.HE's 48.76%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
44.92%
5Y equity/share CAGR above 1.5x UPM.HE's 13.98%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.06%
3Y equity/share CAGR above 1.5x UPM.HE's 19.36%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.97%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-6.14%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.88%
Positive asset growth while UPM.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.87%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-1.33%
We’re deleveraging while UPM.HE stands at 0.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
20.82%
SG&A growth of 20.82% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.